Klara Pecankova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: October 17, 2022

The Relation Between Protein Adsorption and Hemocompatibility of Antifouling Polymer Brushes.

The Relation Between Protein Adsorption and Hemocompatibility of Antifouling Polymer Brushes.

Journal: Macromolecular bioscience

Published: June 15, 2022

Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome.

Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 11, 2022

Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.

Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.

Journal: International journal of molecular sciences

Published: November 27, 2021

Complement Activation Dramatically Accelerates Blood Plasma Fouling On Antifouling Poly(2-hydroxyethyl methacrylate) Brush Surfaces.

Complement Activation Dramatically Accelerates Blood Plasma Fouling On Antifouling Poly(2-hydroxyethyl methacrylate) Brush Surfaces.

Journal: Macromolecular bioscience

Published: November 16, 2021

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome.

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome.

Journal: PloS one

Published: August 20, 2021

SPR biosensor for quantification of fetuin-A as a promising multibiomarker.

SPR biosensor for quantification of fetuin-A as a promising multibiomarker.

Journal: Physiological research

Published: November 01, 2018

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

Journal: Cancer biomarkers : section A of Disease markers

Published: September 05, 2017

Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.

Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: September 10, 2016

Disulfide subproteome alterations in the platelets of patients with myelodysplastic syndrome.

Disulfide subproteome alterations in the platelets of patients with myelodysplastic syndrome.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: February 09, 2016

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups.

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups.

Journal: International journal of laboratory hematology

Published: May 07, 2015

Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome.

Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome.

Journal: BioMed research international

Published: September 23, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026